Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

By G. D'Haens, F. Baert, G. Van Assche, P. Caenepeel, P. Vergauwe, H. Tuynman, M. De Vos, Sander J. van Deventer, L. Stitt, Allan Donner and 12 more. The Lancet, 2008

1,148 citations recorded by the source corpus.

Subfields: Epidemiology, Genetics, Rheumatology

View Paper: https://www.semanticscholar.org/paper/0cde4440c366d2d3dc208667ca5d2451ae498468

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. C. Mowat
2. A. Cole
3. J. Satsangi
4. C. Lees
5. I. Arnott
6. R. Driscoll
7. S. Mitton
8. T. Orchard

Citations in the corpus

• Guidelines for the management of inflammatory bowel disease in adults (2011, background): “In newly diagnosed patients with Crohn's disease, which patients should be offered early anti-TNF therapy? The top-down approach”